TP53 and breast cancer: Moreover, the clinicopathological significance of p53, PCNA, c-erbB-2, and apoptosis, relatively new prognostic factors, and conventional prognostic factors, especially lymph-node status was evaluated in predicting relapse-free survival (RFS) and overall survival (OS) rates with a long-term follow-up in Japanese patients with breast cancer.